Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells
- 1 November 2003
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 419 (2) , 110-119
- https://doi.org/10.1016/j.abb.2003.08.034
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Enzymes of Sphingolipid Metabolism: From Modular to Integrative SignalingBiochemistry, 2001
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissuesInternational Journal of Cancer, 1999
- p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS–KCNR human neuroblastoma cell lineOncogene, 1998
- Myc activates telomeraseGenes & Development, 1998
- Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?European Journal Of Cancer, 1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Programmed Cell Death Induced by CeramideScience, 1993
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984